Naos Yaron has filed 4 insider transactions across 1 company since August 2023.
Most recent transaction: a grant/award of 25000 shares of Protalix BioTherapeutics, Inc. ($PLX) on September 03, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sept. 3, 2025 | Protalix BioTherapeutics, Inc. | $PLX | Naos Yaron | Sr. VP, Operations | A | Common Stock | 25000 | $0.00 | 232,929.0000 | 81,271,610 | 12.02% | 0.03% |
| Sept. 3, 2025 | Protalix BioTherapeutics, Inc. | $PLX | Naos Yaron | Sr. VP, Operations | A | Stock Option (Right to Buy) | 50000 | $0.00 | 50,000.0000 | 81,271,610 | 9999.99% | 0.06% |
| Sept. 23, 2024 | Protalix BioTherapeutics, Inc. | $PLX | Naos Yaron | Sr. VP, Operations | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 73,308,281 | 9999.99% | 0.14% |
| Aug. 15, 2023 | Protalix BioTherapeutics, Inc. | $PLX | Naos Yaron | Sr. VP, Operations | A | Common Stock | 187344 | $0.00 | 207,929.0000 | 83,200,641 | 910.10% | 0.23% |